Emerald Health Therapeutics fait part des progrès accomplis dans son programme de production et de traitement
August 06, 2019 15:59 ET
|
Emerald Health Therapeutics Inc.
VICTORIA (Colombie-Britannique, Canada), 06 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (ci-après « Emerald », TSXV : EMH ; OTCQX : EMHTF) a communiqué aujourd'hui les...
Emerald Health Therapeutics Outlines Production and Processing Advancements
August 06, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today provided updates on its various cultivation and processing...
Emerald Health Therapeutics’ New Organic Cannabis Operation Receives Cultivation License for Outdoor Grow Area
July 15, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, July 15, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has received its cultivation license from Health Canada for the...
HEXO MED, une filiale de HEXO Corp, obtient une licence pour la production de cannabis médical en Europe
June 13, 2019 06:30 ET
|
HEXO Corp.
ATHÈNES, Grèce, 13 juin 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE-A : HEXO) a le plaisir d'annoncer que sa filiale, HEXO MED S.A. (« HEXO MED ») a...
HEXO MED, an affiliate of HEXO Corp, secures medical cannabis license in Europe
June 13, 2019 06:30 ET
|
HEXO Corp.
ATHENS, Greece, June 13, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is pleased to announce that its affiliate, HEXO MED S.A. (“HEXO MED”) has received a...
Emerald Health Therapeutics Announces Pure Sunfarms’ Receipt of Standard Processing License for Delta 3 Greenhouse Facility
May 20, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 20, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its 50%-owned joint venture for...
Emerald Health Therapeutics Announces Pure Sunfarms’ Delta 3 Greenhouse is Fully Planted; Reporting Year End Financials May 1st
April 23, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
Pure Sunfarms on track to reach annual production run-rate of 75,000 kilograms by mid-2019 Company to host 2018 fourth quarter and year end financial results conference call Wednesday, May 1, 2019 at...
WeedMD Acquires 60 Acres of Neighbouring Land to Expand its Outdoor Cannabis Footprint
April 10, 2019 07:05 ET
|
WeedMD Rx Inc.
TORONTO, April 10, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is...
Emerald’s Pure Sunfarms Joint Venture Acquires Second 1.1 Million Square Foot Greenhouse, Doubling Potential Production Capacity to 150,000 Kilograms
April 01, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its 50%-owned joint venture, Pure...
YIELD GROWTH Engages Faculty of Pharmaceutical Sciences, UBC to Conduct Analysis of Bioactive Compounds in Proprietary Hemp Root Oil
March 14, 2019 08:30 ET
|
The Yield Growth Corp.
VANCOUVER, British Columbia, March 14, 2019 (GLOBE NEWSWIRE) -- The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (Frankfurt:YG3) has engaged the Faculty of Pharmaceutical Sciences at the University...